Video Experimental Relacionado
Updated: Jan 15, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.4K
Variabilidad en la Dosis de Antibióticos y Desarrollo de Resistencia Durante la Terapia de Reemplazo Renal Continuo
Blood purification
|January 13, 2026
Resumen
La optimización de la dosis de antibióticos para pacientes críticos en terapia de reemplazo renal continuo (CRRT) es crucial. Las dosis subóptimas de antibióticos durante la CRRT se vincularon con un aumento de la resistencia en análisis exploratorios.
Área de la Ciencia:
- Medicina de Cuidados Críticos
- Farmacología
- Nefrología
Sus antecedentes:
- La dosificación de antibióticos en pacientes críticos en terapia de reemplazo renal continuo (CRRT) presenta desafíos significativos.
- La alteración de la farmacocinética, la variabilidad de la CRRT y la limitada orientación exigen una dosificación optimizada para prevenir la resistencia a los antibióticos y la toxicidad.
Objetivo del estudio:
- Evaluar las estrategias de dosificación de antibióticos en pacientes de la unidad de cuidados intensivos (UCI) que reciben CRRT.
- Investigar la asociación entre los parámetros de CRRT, la dosificación de antibióticos y el desarrollo de resistencia antimicrobiana.
Principales métodos:
- Estudio retrospectivo unicéntrico de pacientes de UCI que recibieron CRRT y cefepima, meropenem o piperacilina-tazobactam.
- Análisis de la dosis de CRRT administrada, las dosis diarias de antibióticos y el desarrollo de resistencia en Pseudomonas aeruginosa y Enterobacter cloacae.
Principales resultados:
- La mayoría de los pacientes recibieron dosis de CRRT más altas que las recomendadas por las directrices KDIGO.
- Las dosis diarias más bajas de antibióticos durante la CRRT se asociaron de forma independiente con un aumento de la resistencia a cefepima y meropenem.
- Se observó resistencia emergente durante el tratamiento en P. aeruginosa y E. cloacae.
Conclusiones:
- Las dosis de antibióticos administradas durante la CRRT a menudo estuvieron por debajo de los rangos terapéuticos.
- Los hallazgos sugieren que las estrategias de dosificación informadas por la CRRT pueden ser importantes para controlar la resistencia a los antibióticos.
- Es esencial equilibrar la eficacia y la toxicidad de los antibióticos en pacientes con CRRT.
Videos de Conceptos Relacionados
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
207
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
207
01:30Continuous Renal Replacement Therapy
817
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
817
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
232
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
232
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
174
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
174
01:11Renal Failure: Dose Adjustments
434
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
434
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
232
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
232